This trend, more evident in MS mothers, and the divergence in HERV and TRIM28/SETDB1 expressions both in peripheral blood and in the placenta of MS mothers compared to healthy mothers are difficult to explain by distinct plasma levels of any hormone or other circulating factor. Here, SETDB1 is linked to myeloid sarcoma.